+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer



Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer



Annals of Surgical Oncology 17(2): 441-447



We previously reported 26 patients who underwent preoperative chemoradiotherapy (CXRT) for T3 rectal cancer and were subsequently offered full-thickness local excision (LE) as an alternative to total mesorectal excision (TME). At nearly 4 years' follow-up, no difference in outcome was observed. This study compares outcomes in a larger cohort of patients and reevaluates the original 26 patients after longer follow-up. Retrospective review was performed of patients who underwent preoperative CXRT (radiation doses of 45, 50.4, or 52.5 Gy with concurrent 5-fluorouracil-based chemotherapy) followed by surgery for T3 rectal cancer. Forty-seven patients underwent LE (Kraske [n = 6] or transanal excision [n = 41]). 473 patients underwent TME (abdominoperineal resection [n = 141] or low anterior resection [n = 332]). Local recurrence, disease-free survival (DFS), disease-specific survival, and overall survival (OS) rates were compared. Median follow-up was 63 months for the LE group and 59 months for the TME group. Twenty-three LE patients (49%) had a complete response to CXRT, 17 (36%) had microscopic residual disease, and 7 (15%) had gross residual disease, compared with 108 (23%), 89 (19%), and 276 (58%) TME patients, respectively. There was no significant difference between the 10-year actuarial local recurrence rate for the LE group versus the TME group (10.6% and 7.6%, respectively; P = .52), and no significant difference in DFS, disease-specific survival, or OS rates between groups. In selected patients who demonstrate an excellent response to preoperative CXRT for T3 rectal cancer, full-thickness LE offers comparable local control, DFS, and OS to that achieved with proctectomy and TME.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054151351

Download citation: RISBibTeXText

PMID: 19847569

DOI: 10.1245/s10434-009-0735-7


Related references

Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. International Journal of Radiation Oncology, Biology, Physics 60(4): 1098-1105, 2004

Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation. Medicine 94(45): E1971, 2016

Preoperative chemoradiation and total mesorectal excision surgery for low T3 rectal cancer. Tumori 87(4): S31-S33, 2001

Total Mesorectal Excision Versus Local Excision After Preoperative Chemoradiotherapy in Rectal Cancer With Lymph Node Metastasis: A Propensity Score-Matched Analysis. International Journal of Radiation Oncology, Biology, Physics 101(3): 630-639, 2018

Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer. Annals of Surgical Oncology 23(1): 106-113, 2016

Safety of laparoscopic total mesorectal excision for low rectal cancer with preoperative chemoradiation therapy. Journal of Gastrointestinal Surgery 13(3): 521-525, 2008

A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Diseases of the Colon and Rectum 46(3): 298-304, 2003

C-Reactive Protein Level Predicts Survival Outcomes in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation Therapy. Annals of Surgical Oncology 25(13): 3898-3905, 2018

Adjuvant Chemotherapy in Rectal Cancer Patients Treated with Preoperative Chemoradiation and Total Mesorectal Excision: A Multicenter and Retrospective Propensity-Score Matching Study. International Journal of Radiation Oncology, Biology, Physics 2018, 2018

Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution. Journal of the National Comprehensive Cancer Network 16(7): 822-828, 2018

Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary. Diseases of the Colon and Rectum 58(6): 556-565, 2015

Factors associated with local recurrence after neoadjuvant chemoradiation with total mesorectal excision for rectal cancer. World Journal of Surgery 33(8): 1741-1749, 2009

Transanal local excision for preoperative concurrent chemoradiation therapy for distal rectal cancer in selected patients. Surgery Today 37(12): 1068-1072, 2007

Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients. Journal of Radiation Research 56(1): 169-176, 2015

Is trans-anal total mesorectal excision really safe and better than laparoscopic total mesorectal excision with a perineal approach first in patients with low rectal cancer? A learning curve with case-matched study in 68 patients. Colorectal Disease 20(6): O143-O151, 2018